2023 annual financial data
MoonLake Immunotherapeutics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -54,123,096 USD and net income was -36,007,260 USD.
Operating cash flow was -42,778,000 USD.
Get free MoonLake Immunotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -54,123,096 USD
- Net income
- -36,007,260 USD
- Operating cash flow
- -42,778,000 USD